Author | Alexander Guminski, MD, PhD | OncLive

Author | Alexander Guminski, MD, PhD

Articles

Dr. Guminski on 16-Month Follow-Up With Cemiplimab in mCSCC

August 29, 2019

Video

Alexander Guminski, MD, PhD, medical oncologist, Royal North Shore Hospital, University of Sydney, discusses the 16-month follow-up results of a phase II trial evaluating cemiplimab (Libtayo) in patients with metastatic cutaneous squamous cell carcinoma.

x